35,99 €
Clinical Guide to Cardiology is a quick-reference resource, packed full of bullet points, diagrams, tables and algorithms for the key concepts and facts for important presentations and conditions within cardiology. It provides practical, evidence-based information on interventions, investigations, and the management of clinical cardiology.
Key features include:
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 529
Veröffentlichungsjahr: 2016
Series Editor: Christian Camm
The Clinical Guides are a brand new resource for junior doctors and medical students.
They provide practical and concise day-to-day information on common conditions, symptoms and problems faced in the clinical environment. They are easy to navigate and allow swift access to information as it is needed, with step-by-step guidance on decision making, investigations and interventions, and how to survive and thrive on clinical rotation and attachment.
This new title is also available as an e-book.For more details, please seewww.wiley.com/buy/9781118755334or scan this QR code:
Edited by
Christian F. Camm
John Radcliffe Hospital, Oxford, UK
A. John Camm
St. George’s University of London, London, UK
This edition first published 2016 © 2016 by John Wiley & Sons, Ltd
Registered office: John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA
For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell
The right of the authors to be identified as the authors of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought.
The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by health science practitioners for any particular patient. The publisher and the author make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the author or the publisher endorses the information the organization or Website may provide or recommendations it may make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared between when this work was written and when it is read. No warranty may be created or extended by any promotional statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom.
Library of Congress Cataloging-in-Publication Data
Clinical guide to cardiology / edited by Christian F. Camm, A. John Camm. p. ; cm. Includes bibliographical references and index. ISBN 978-1-118-75533-4 (pbk.) I. Camm, Christian F. (Christian Fielder), editor. II. Camm, A. John, editor. [DNLM: 1. Heart Diseases–diagnosis. 2. Heart Diseases–therapy. WG 141] RC682 616.1′2–dc23 2015025343
A catalogue record for this book is available from the British Library.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books.
Cover image: iStockphoto/© Nerthuz
Contributors
Acronyms and Abbreviations
About the Companion Website
PART 1 Examination Techniques
1 Examination Techniques
1.1 Common conditions to be looked for on the examination
1.2 Clinical examination – peripheries
1.3 Clinical examination – the praecordium
1.4 How to present your findings
1.5 Eponymous signs and symptoms
Note
PART 2 Approach to Presenting Complaints
2 Chest Pain
2.1 Definition
2.2 Diagnostic algorithm
2.3 Differentials list
2.4 Key history features
2.5 Key examination features
2.6 Key investigations
2.7 When to call a senior
Key clinical trials
Guidelines
Further reading
3 Shortness of Breath
3.1 Definition
3.2 Diagnostic algorithm
3.3 Differentials list
3.4 Key history features
3.5 Key examination features
3.6 Key investigations
3.7 When to call a senior
Guidelines
Further reading
4 Loss of Consciousness
4.1 Definition
4.2 Classification
4.3 Differentials list
4.4 Key history features
4.5 Key examination features
4.6 Key investigations
4.7 When to call a senior
4.8 Key clinical trials
Guidelines
Further reading
5 Palpitations
5.1 Definition
5.2 Diagnostic algorithm
5.3 Differentials list
5.4 Key history features
5.5 Key examination features
5.6 Key investigations
5.7 When to call a senior
Guidelines
Further reading
6 Cardiac Murmurs
6.1 Definition
6.2 Classification
6.3 Differentials list
6.4 Key history features
6.5 Key examination features
6.6 Key investigations
6.7 When to call a senior
Key clinical trials
Guidelines
Further reading
7 Shock
7.1 Definition
7.2 Diagnostic algorithm
7.3 Differentials list
7.4 Key history features
7.5 Key examination features
7.6 Key investigations
7.7 When to call a senior
Key clinical trials
Guidelines
Further reading
8 Oedema
8.1 Definition
8.2 Diagnostic algorithm
8.3 Differentials list
8.4 Key history features
8.5 Key examination features
8.6 Key investigations
8.7 When to call a senior
Key clinical trials
Guidelines
Further reading
PART 3 Conditions
9 Acute Coronary Syndrome
9.1 Definition
9.2 Underlying concepts
9.3 Key data
9.4 Clinical types
9.5 Presenting features
9.6 Differentials
9.7 Key investigations
9.8 Management options
Key clinical trials
Guidelines
Further reading
10 Stable Angina
10.1 Definition
10.2 Underlying concepts
10.3 Key data
10.4 Clinical types
10.5 Presenting features
10.6 Differentials
10.7 Key investigations
10.8 Management options
Key clinical trials
Guidelines
Further reading
11 Heart Failure
11.1 Definition
11.2 Underlying concepts
11.3 Clinical types
11.4 Heart failure with reduced ejection fraction
11.5 Heart failure with preserved ejection fraction (HF-PEF)
Key clinical trials
Guidelines
Further reading
12 Infective Endocarditis
12.1 Definition
12.2 Underlying concepts
12.3 Key data
12.4 Clinical types
12.5 Presenting features
12.6 Differentials
12.7 Key investigations
12.8 Management options
Key clinical trials
Guidelines
Further reading
13 Arrhythmias
13.1 Definition
13.2 Underlying concepts
13.3 Clinical types
13.4 Atrial fibrillation
13.5 Atrial flutter
13.6 Supraventricular tachycardias
13.7 Ventricular tachycardia
13.8 Other arrhythmias to be aware of
Key clinical trials
Guidelines
Further reading
14 Valvular Heart Disease
14.1 Definition
14.2 Underlying concepts
14.3 Clinical types
14.4 Mitral regurgitation (MR)
14.5 Mitral stenosis (MS)
14.6 Aortic stenosis (AS)
14.7 Aortic regurgitation (AR)
14.8 Other murmurs to be aware of
Key clinical trials
Guidelines
Further reading
15 Cardiomyopathy
15.1 Definition
15.2 Underlying concepts
15.3 Clinical types
15.4 Presentation
15.5 Hypertrophic cardiomyopathy
15.6 Dilated cardiomyopathy
15.7 Restrictive cardiomyopathy
15.8 Other cardiomyopathies
Guidelines
Further reading
16 Hypertension
16.1 Definition
16.2 Underlying concepts
16.3 Key data
16.4 Clinical types
16.5 Presenting features
16.6 Differentials
16.7 Key investigations
16.8 Management options
Key clinical trials
Guidelines
Further reading
17 Pericardial Disease
17.1 Definition
17.2 Underlying concepts
17.3 Clinical types
17.4 Acute pericarditis
17.5 Constrictive pericarditis
17.6 Pericardial effusion
Key clinical trials
Guidelines
Further reading
18 Congenital Heart Disease
18.1 Definition
18.2 Underlying concepts
18.3 Atrial septal defect
18.4 Ventricular septal defect
18.5 Coarctation of the aorta
18.6 Other forms of congenital heart disease
Key clinical trials
Guidelines
Further reading
PART 4 Imaging
19 Electrocardiogram
19.1 Definition
19.2 Outline of procedure
19.3 Indications
19.4 Peri-procedural management
19.5 Key features
19.6 Interpretation
19.7 Potential complications
Guidelines
Further reading
20 Transoesophageal Echocardiogram
20.1 Definition
20.2 Outline of procedure
20.3 Indications
20.4 Peri-procedural management
20.5 Interpretation
20.6 Potential complications
Guidelines
Further reading
21 Trans-Thoracic Echocardiogram
21.1 Definition
21.2 Outline of procedure
21.3 Indications
21.4 Peri-procedural management
21.5 Interpretation
21.6 Potential complications
Guidelines
22 Cardiac MRI
22.1 Definition
22.2 Outline of procedure
22.3 Indications
22.4 Peri-procedural management
22.5 Interpretation
22.6 Potential complications
Key clinical trials
Guidelines
Further reading
23 Cardiac CT
23.1 Definition
23.2 Outline of procedure
23.3 Indications
23.4 Peri-procedural management
23.5 Interpretation
23.6 Potential complications
Key clinical trials
Guidelines
Further reading
24 Cardiac Catheterization
24.1 Definition
24.2 Outline of procedure
24.3 Indications
24.4 Peri-procedural management
24.5 Interpretation
24.6 Potential complications
Guidelines
Further reading
PART 5 Interventional Therapies
25 Pacemakers and Implantable Cardiac Defibrillators
25.1 Definition
25.2 Outline of devices
25.3 Outline of procedure
25.4 Indications
25.5 Peri-procedural management
25.6 Potential complications
Key clinical trials
Guidelines
26 Percutaneous Coronary Intervention and Angioplasty
26.1 Definition
26.2 Basic principles
26.3 Outline of procedure
26.4 Indications
26.5 Peri-procedural management
26.6 Interpretation
26.7 Potential complications
26.8 Thrombolysis
Key clinical trials
Guidelines
Further reading
27 Valvuloplasty
27.1 Definition
27.2 Outline of procedure and devices
27.3 Indications
27.4 Peri-procedural management
27.5 Potential complications
Guidelines
28 Transcatheter Aortic Valve Implantation
28.1 Definition
28.2 Outline of procedure and devices
28.3 Indications
28.4 Peri-procedural management
28.5 Potential complications
Key clinical trials
Guidelines
Further reading
29 Cardiac Ablation
29.1 Definition
29.2 Outline of procedure
29.3 Indications
29.4 Peri-procedural management
29.5 Potential complications
Key clinical trials
Guidelines
Further reading
PART 6 Pharmacology
30 Anti-Arrhythmic Agents
30.1 Adenosine
30.2 Amiodarone
30.3 Flecainide
30.4 Digoxin
30.5 Atropine
Key clinical trials
31 Beta-Blockers
31.1 General notes
31.2 Non-selective
31.3 Cardioselective
Key clinical trials
32 Calcium-Channel Blockers
32.1 General notes
32.2 Cardiac selective
32.3 Action primarily on vascular smooth muscle
Key clinical trials
33 Nitrates
33.1 General notes
33.2 Oral nitrates
33.3 Nitrates used as an infusion
Key clinical trials
34 Drugs Targeting the Angiotensin Axis
34.1 General notes
34.2 ACE inhibitors (ACEi)
34.3 Angiotensin-receptor blockers
35 Diuretics
35.1 Loop diuretics
35.2 Thiazides and thiazide-like diuretics
35.3 Potassium-sparing diuretics
Key trials
36 Anticoagulants
36.1 Heparin
36.2 Low molecular weight heparins (LMWHs)
36.3 Fondaparinux
36.4 Warfarin
36.5 Novel oral anticoagulants
Key trials
37 Antiplatelets
37.1 Aspirin
37.2 Clopidogrel
37.3 Novel antiplatelets
38 Lipid Regulation
38.1 Statins
Index
EULA
Chapter 1
Table 1.1
Table 1.2
Table 1.3
Table 1.4
Table 1.5
Table 1.6
Table 1.7
Table 1.8
Table 1.9
Table 1.10
Table 1.11
Table 1.12
Table 1.13
Table 1.14
Chapter 2
Table 2.1
Table 2.2
Table 2.3
Table 2.4
Chapter 3
Table 3.1
Table 3.2
Table 3.3
Table 3.4
Table 3.5
Table 3.6
Chapter 4
Table 4.1
Table 4.2
Table 4.3
Table 4.4
Chapter 5
Table 5.1
Table 5.2
Table 5.3
Table 5.4
Chapter 6
Table 6.1
Table 6.2
Table 6.3
Table 6.4
Chapter 7
Table 7.1
Table 7.2
Table 7.3
Table 7.4
Table 7.5
Table 7.6
Table 7.7
Table 7.8
Chapter 8
Table 8.1
Table 8.2
Table 8.3
Table 8.4
Table 8.5
Chapter 9
Table 9.1
Table 9.2
Table 9.3
Table 9.4
Table 9.5
Table 9.6
Table 9.7
Table 9.8
Table 9.9
Table 9.10
Table 9.11
Table 9.12
Table 9.13
Chapter 10
Table 10.1
Table 10.2
Table 10.3
Table 10.4
Table 10.5
Chapter 11
Table 11.1
Table 11.2
Table 11.3
Table 11.4
Table 11.5
Table 11.6
Table 11.7
Table 11.8
Chapter 12
Table 12.1
Table 12.2
Table 12.3
Table 12.4
Table 12.5
Table 12.6
Table 12.7
Table 12.8
Table 12.9
Table 12.10
Table 12.11
Table 12.12
Chapter 13
Table 13.1
Table 13.2
Table 13.3
Table 13.4
Table 13.5
Table 13.6
Table 13.7
Table 13.8
Table 13.9
Table 13.10
Table 13.11
Table 13.12
Table 13.13
Table 13.14
Table 13.15
Table 13.16
Table 13.17
Table 13.18
Table 13.19
Chapter 14
Table 14.1
Table 14.2
Table 14.3
Table 14.4
Table 14.5
Table 14.6
Table 14.7
Table 14.8
Table 14.9
Table 14.10
Table 14.11
Table 14.12
Table 14.13
Table 14.14
Table 14.15
Table 14.16
Table 14.17
Table 14.18
Table 14.19
Table 14.20
Table 14.21
Table 14.22
Table 14.23
Table 14.24
Table 14.25
Table 14.26
Table 14.27
Table 14.28
Chapter 15
Table 15.1
Table 15.2
Table 15.3
Table 15.4
Table 15.5
Table 15.6
Table 15.7
Table 15.8
Table 15.9
Table 15.10
Table 15.11
Table 15.12
Table 15.13
Table 15.14
Table 15.15
Table 15.16
Chapter 16
Table 16.1
Table 16.2
Table 16.3
Table 16.4
Table 16.5
Table 16.6
Table 16.7
Table 16.8
Table 16.9
Table 16.10
Table 16.11
Table 16.12
Chapter 17
Table 17.1
Table 17.2
Table 17.3
Table 17.4
Table 17.5
Table 17.6
Table 17.7
Table 17.8
Table 17.9
Table 17.10
Table 17.11
Table 17.12
Table 17.13
Table 17.14
Table 17.15
Chapter 18
Table 18.1
Table 18.2
Table 18.3
Table 18.4
Table 18.5
Table 18.6
Table 18.7
Table 18.8
Table 18.9
Table 18.10
Table 18.11
Table 18.12
Table 18.13
Table 18.14
Table 18.15
Table 18.16
Table 18.17
Table 18.18
Chapter 19
Table 19.1
Table 19.2
Table 19.3
Table 19.4
Table 19.5
Table 19.6
Table 19.7
Table 19.8
Table 19.9
Table 19.10
Table 19.11
Table 19.12
Table 19.13
Table 19.14
Table 19.15
Chapter 20
Table 20.1
Chapter 21
Table 21.1
Chapter 22
Table 22.1
Chapter 23
Table 23.1
Table 23.2
Chapter 24
Table 24.1
Table 24.2
Chapter 25
Table 25.1
Table 25.2
Chapter 26
Table 26.1
Chapter 27
Table 27.1
Chapter 28
Table 28.1
Chapter 29
Table 29.1
Chapter 36
Table 36.1
Table 36.2
Chapter 1
Figure 1.1
The examination circuit.
Chapter 2
Figure 2.1
Algorithm for the diagnosis of chest pain.
Figure 2.2
Stanford classification.
Figure 2.3
ECG changes of acute anterior ST-Elevation MI.
Chapter 3
Figure 3.1
Diagnostic algorithm for shortness of breath.
Figure 3.2
Examination findings in acute pulmonary oedema.
Figure 3.3
Examination findings in pulmonary embolism.
Figure 3.4
Examination findings in pneumothorax.
Figure 3.5
Examination findings in asthma.
Figure 3.6
Examination findings in pneumonia.
Figure 3.7
Examination findings in pleural effusion.
Figure 3.8
Graphical representation of restrictive and obstructive pulmonary function test results.
Figure 3.9
ECG of a patient with a pulmonary embolism showing the classic S1,Q3,T3 pattern.
Figure 3.10
CXR showing a pleural effusion.
Figure 3.11
CXR showing a right upper-lobe pneumonia.
Figure 3.12
CXR showing a right sided pneumothorax.
Chapter 4
Figure 4.1
Classification of T-LOC aetiology
Figure 4.2
An ECG showing complete dissociation of atrial and ventricular systole. This is consistent with third-degree (complete) heart block. These patients often present with syncope – so-called Stokes Adam's attacks.
Figure 4.3
CT pulmonary angiogram showing a filling defect in the right and left pulmonary arteries consistent with bilateral pulmonary emboli.
Chapter 5
Figure 5.1
Flow chart for evaluation of palpitations.
Figure 5.2
A REVEAL™ device – used for palpitations/syncope of unknown origin.
Chapter 6
Figure 6.1
Flow-chart of potential underlying causes for murmurs based on timing.
Figure 6.2
Heavily calcified aortic valve (AV) in a patient with severe aortic stenosis. There is concentric hypertrophy of the left ventricular (LV) wall and post-stenotic dilatation of the aorta (A). LA, left atrium.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.3
Mitral regurgitation. Doppler shows a jet of blood passing from the left ventricle (LV) into the left atrium (LA). RV, right ventricle; RA, right atrium.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.4
Aortic regurgitation, Doppler imaging shows a jet of blood directed back into the left ventricle (LV) from the aorta. AV, aortic valve; LA, left atrium; RA, right atrium.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.5
Mitral stenosis. The mitral valve (MV) is heavily calcified. The left atrium (LA) is dilated. LV, left ventricle.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.6
Ventricular septal defect (VSD), Doppler imaging shows the movement of blood across the opening. RV, right ventricle; RA, right atrium; vS, ventricular septum; LV, left ventricle; LA, left atrium.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.7
Atrial septal defect (ASD), Doppler imaging shows the movement of blood across the opening. RA, right atrium; LA, left atrium; aS, atrial septum; RV, right ventricle.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.8
Vegetation (V) on aortic valve in a patient with infective endocarditis. LV, left ventricle; MV, mitral valve; LA, left atrium.Source: Harpreet Kaur Sahemey, Echocardiographer, Hammersmith Hospital.
Figure 6.9
Work-up of a patient who presents with a murmur.
Chapter 7
Figure 7.1
Diagnostic flow chart for shock.
Figure 7.2
Pneumocystis pneumonia (PCP) – a potential cause of septic shock in immunocompromised patients. Source: Daniel Hughes, FY2 Doctor in Radiology, Queen Elizabeth Hospital, Woolwich.
Figure 7.3
A large right-sided pneumothorax; if this begins to tension it could become a cause of obstructive shock.
Chapter 8
Figure 8.1
Flow chart detailing the pathophysiology of oedema.
Chapter 9
Figure 9.1
The development of acute coronary syndrome.
Figure 9.2
Diagram of coronary occlusion, due to an atherosclerotic plaque and associated thrombus, with downstream infarction.
Figure 9.3
Cardiac markers: approximate levels vs. time of onset post MI.
Figure 9.4
Diagnostic algorithm for differentiating different forms of ACS.
Figure 9.5
Cartoon representation of the pathological features following myocardial infarction.
Figure 9.6
Conditions mimicking non-ST-elevation myocardial infarctions.
Figure 9.7
ECG changes seen over time in ST-elevation myocardial infarction.
Figure 9.8
Management of patients with ACS.
Figure 9.9
Simplified platelet activation pathway.
Chapter 10
Figure 10.1
A partially occluded coronary artery.
Figure 10.2
Modifiable and non-modifiable risk factors for coronary artery disease.
Figure 10.3
Right hand showing nicotine stains on the index and middle fingers.
Figure 10.4
ECG showing ischaemic changes of someone with stable angina.
Figure 10.5
Investigations for stable angina.
Chapter 11
Figure 11.1
The Frank–Starling curve.
Figure 11.2
Chest radiograph showing pulmonary oedema. Note the presence of cardiomegaly, bilateral pleural effusions and ‘bat's wing’ appearance of the hili.
Figure 11.3
Enlarged chest radiograph showing Kerley B lines. These are short horizontal lines seen at the periphery of the radiograph and are a feature of pulmonary oedema.
Figure 11.4
Diagnostic algorithm for heart failure.
Figure 11.5
Flow chart for the management of heart failure.
Chapter 12
Figure 12.1
Aortic valve vegetation from infective endocarditis. Source: Mr Gopal Soppa, Academic Clinical Lecturer in Cardiothoracic Surgery, St. George's University of London.
Figure 12.2
Hand signs of infective endocarditis.
Figure 12.3
Clubbing. Source: Patrick Jahns, King's College Hospital NHS Foundation Trust.
Figure 12.4
First-degree heart block.
Figure 12.5
Trans-thoracic echocardiogram showing vegetation on the mitral valve.
Chapter 13
Figure 13.1
Normal conduction within the heart.
Figure 13.2
12-lead ECG showing atrial fibrillation.
Figure 13.3
ESC rhythm control flow chart. Source: Camm 2012. reproduced with permission of Oxford University Press. CAD, coronary artery disease; CHF, congestive heart failure; HT, hypertension; LVH, left ventricular hypertrophy.
Figure 13.4
12-lead ECG showing atrial flutter.
Figure 13.5
Supraventricular tachycardia starting in a patient.
Figure 13.6
12-lead ECG showing ventricular tachycardia.
Figure 13.7
12-lead ECG of multifocal atrial tachycardia.
Chapter 14
Figure 14.1
Diagrammatic representation of heart chamber and valves. Note the mitral valve is the only valve with two leaflets.
Figure 14.2
Auscultation locations for cardiac valves.
Figure 14.3
Auscultatory findings in mitral regurgitation.
Figure 14.4
Auscultatory findings in mitral stenosis. Note the presence of presystolic potentiation due to atrial systole (increased amplitude of murmur in figure), which is only seen in sinus rhythm.
Figure 14.5
Auscultatory findings in aortic stenosis.
Figure 14.6
Auscultatory findings in aortic regurgitation.
Chapter 15
Figure 15.1
Clinical types of cardiomyopathy. (a) Normal heart. (b) HCM with the characteristically enlarged ventricular walls. (c) DCM characterized by enlarged ventricles which attempt to compensate for ventricular dysfunction. (d) RCM characterized by infiltration which stiffens the ventricular walls and causes diastolic dysfunction.
Figure 15.2
Pathophysiology of HCM.
Figure 15.3
12-lead sinus rhythm ECG in HCM patient showing prominent left ventricular hypertrophy (Sokolow criteria). Source: TP Mast, MD, and MJM Cramer, MD, University Medical Center Utrecht, the Netherlands.
Figure 15.4
TTE in HCM. Parasternal long-axis TTE in HCM patient showing prominent septal hypertrophy (A and B), as well as septal anterior motion (anterior leaflet of mitral valve touching the septum in systole, B). Source: TP Mast, MD, and MJM Cramer, MD, University Medical Center Utrecht, the Netherlands.
Figure 15.5
Pathophysiology of DCM.
Figure 15.6
Chest X-ray in DCM patient showing enlarged heart with cardiothoracic ratio (CTR) >0.5. Source: BK Velthuis, MD, University Medical Center Utrecht, the Netherlands.
Figure 15.7
MRI IN DCM. Cardiac magnetic resonance imaging in DCM patient in the four-chamber (A) and short-axis (B) view showing an enlarged LV (end-diastolic volume 330 mL) with reduced wall thickness and reduced function (ejection fraction 28%).Source: BK Velthuis, MD, University Medical Center Utrecht, the Netherlands.
Figure 15.8
Pathophysiology of RCM.
Chapter 16
Figure 16.1
Autoregulation. Blood flow in an organ is maintained constant despite fluctuations in blood pressure through means of myogenic and metabolic mechanisms. In chronic hypertension there is a rightward shift in this relationship making them more vulnerable to hypoperfusion with lowering of blood pressure.
Figure 16.2
Management of hypertension. Source: NICE 2011. Reproduced with permission of NICE.
Chapter 17
Figure 17.1
12-lead electrocardiogram from a patient with acute pericarditis showing widespread ST-segment elevation and PR-segment depression.
Figure 17.2
Flowchart of acute pericarditis management.
Figure 17.3
CT chest showing pericardial effusion.
Figure 17.4
Chest X-ray showing a large pericardial effusion.
Figure 17.5
Trans-thoracic echocardiogram of a pericardial effusion.
Chapter 18
Figure 18.1
Atrial septal defect.
Figure 18.2
Ventricular septal defect.
Figure 18.3
Diagram of Fallot's tetralogy.
Figure 18.4
Diagram of transposition of the great arteries.
Chapter 19
Figure 19.1
Image of lead placement both within the limbs and on the chest.
Figure 19.2
Direction of ECG limb leads.
Figure 19.3
The view each lead provides of the heart. Note the two separate axes (coronal and axial).
Figure 19.4
ECG waves and segments.
Figure 19.5
ECG graph paper detailing the technical aspects of an ECG.
Figure 19.6
Axis of overall ventricular depolarization.
Figure 19.7
Standard information found on most ECG print outs. Axis of the atrial (P) and ventricular (QRS) depolarization are displayed as the fourth item on the list.
Figure 19.8
P-wave morphology. (A) Normal morphology. (B) ‘Pulmonale’ P-wave due to right atrial enlargement. (C) ‘Mitrale’ P-wave due to left atrial enlargement.
Figure 19.9
ECG – sinus rhythm.
Figure 19.10
ECG – sinus arrhythmia.
Figure 19.11
ECG – supraventricular tachycardia.
Figure 19.12
ECG – left bundle branch block.
Figure 19.13
ECG – right bundle branch block.
Figure 19.14
ECG – polymorphic ventricular tachycardia (torsades de pointes).
Chapter 20
Figure 20.1
TOE probe.
Figure 20.2
Positioning of TOE probe.
Figure 20.3
TOE image of an aortic dissection.
Figure 20.4
Copy of a TOE report.
Chapter 21
Figure 21.1
Echocardiogram machine.
Figure 21.2
Parasternal long-axis view (TTE) showing the left ventricle (LV), left atrium (LA), and right ventricle (RV). The mitral and aortic valves are also seen.
Figure 21.3
Parasternal short-axis view (TTE) showing typical mitral valve ‘fish mouth view’.
Figure 21.4
Sub-costal view. Showing the left (LA) and right (RA) atria and the left (LV) and right (RV) ventricles.
Figure 21.5
Sample TTE report.
Chapter 22
Figure 22.1
Line drawing of a typical MRI scanner.
Figure 22.2
Normal cardiac MRI.
Figure 22.3
Delayed gadolinium hyper-enhancement.
Chapter 23
Figure 23.1
Multi-detector CT uses multiple rows (often ≥ 64) of detectors opposite the X-ray beams. The more detectors present the faster the speed of image acquisition. The ring is known as the gantry. This rotates around the patient as the patient passes through the ring at a set speed.
Figure 23.2
Axial slice of a cardiac CT for calcium scoring demonstrating a calcified plaque in the right mid stem of the RCA. The Agastson score was 115 for this vessel.
Figure 23.3
Axial slice of a CT contrast coronary angiogram demonstrating the left main stem which is unobstructed.
Figure 23.4
CT contrast coronary angiogram is used to create a 3D reconstruction of the coronary arteries to allow detailed views of the anatomy.
Chapter 24
Figure 24.1
Cardiac catheterization suite.
Figure 24.2
Sample cardiac catheters.
Figure 24.3
Fluoroscopic imaging: left ventriculogram.
Figure 24.4
Fluoroscopic imaging: aortogram.
Chapter 25
Figure 25.1
Line drawing of a single-chamber pacemaker
in situ
.
Figure 25.2
Line drawing of a dual-chamber pacemaker
in situ
.
Figure 25.3
Line drawing of a bi-ventricular pacemaker
in situ
.
Figure 25.4
Line drawing of an implantable cardiac defibrillator. The LV and RA leads are optional.
Figure 25.5
Selection of pacemaker systems for patients with atrioventricular block. Source: Adapted from Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51(21):2085–2105.
Figure 25.6
Selection of pacemaker systems for patients with sinus node dysfunction. Source: Adapted from Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51(21):2085–2105.
Figure 25.7
Chest radiograph of a permanent pacemaker with leads in the right atrium and right ventricle.
Chapter 26
Figure 26.1
Coronary artery anatomy.
Figure 26.2
Origins of the right and left coronary artery (from above the aortic valve).
Figure 26.3
Stenosis of the proximal left circumflex artery.
Figure 26.4
Left circumflex artery post stent insertion.
Chapter 27
Figure 27.1
Fluoroscopy image of guide wire inserted across the aortic valve.
Figure 27.2
Fluoroscopy image of catheter balloon opening the aortic valve.
Chapter 28
Figure 28.1
Insertion of a TAVI valve into place (line drawing).
Figure 28.2
A TAVI valve (Edwards Sapien®). Source: Image kindly provided by Edwards Lifesciences LLC, Irvine, CA. Edwards SAPIEN is a trademark of Edwards Lifesciences Corporation.
Figure 28.3
TAVI valve being inserted and expanded using a transfemoral approach.
Figure 28.4
TAVI valve being inserted and expanded using a transapical approach.
Figure 28.5
TAVI complications.
Chapter 29
Figure 29.1
Pulmonary vein isolation.
Figure 29.2
Ablation of accessory pathway conduction ECG; note disappearance of δ-wave (last two beats).
Figure 29.3
Chest CT showing left-sided pulmonary vein obliteration following pulmonary vein isolation ablation.
Chapter 30
Figure 30.1
Structure of adenosine.
Figure 30.2
Structure of amiodarone.
Figure 30.3
Structure of flecainide.
Figure 30.4
Structure of digoxin.
Figure 30.5
Structure of atropine.
Chapter 31
Figure 31.1
Chemical structure of propranolol.
Figure 31.2
Chemical structure of bisoprolol.
Chapter 32
Figure 32.1
Chemical structure of verapamil.
Figure 32.2
Chemical structure of amlodipine.
Chapter 33
Figure 33.1
Chemical structure of isosorbide mononitrate.
Figure 33.2
Chemical structure of glyceryl trinitrate.
Chapter 34
Figure 34.1
Structure of ramipril.
Figure 34.2
Structure of losartan.
Chapter 35
Figure 35.1
Structure of furosemide.
Figure 35.2
Structure of bendroflumethiazide.
Figure 35.3
Structure of spironolactone.
Chapter 36
Figure 36.1
Structure of fondaparinux.
Figure 36.2
Structure of warfarin.
Figure 36.3
Structure of rivaroxaban.
Chapter 37
Figure 37.1
Structure of aspirin.
Figure 37.2
Structure of clopidogrel.
Figure 37.3
Structure of ticagrelor.
Chapter 38
Figure 38.1
Structure of simvastatin.
Cover
Table of Contents
Part
vii
viii
ix
x
xi
xii
xiii
xiv
1
3
9
10
11
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
61
106
107
108
109
110
111
112
113
114
115
116
117
119
121
122
123
124
125
126
127
128
129
130
131
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
157
158
159
160
161
162
163
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
305
306
307
308
309
310
311
312
313
314
315
317
318
319
320
321
322
323
324
325
326
327
329
330
331
332
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
417
Laura Ah-Kye
King's College Hospital, London, UK
Kristopher Bennett
Whipps Cross Hospital, London, UK
Lucy Carpenter
Barts Health NHS Trust, London, UK
Yang Chen
Imperial College Healthcare NHS Trust, London, UK
Ji-Jian Chow
Queen Elizabeth Hospital, Woolwich, UK
James Cranley
Royal Brompton & Harefield NHS Foundation Trust, London, UK
George Davies
Oxford University Hospitals NHS Trust, Oxford, UK
Akshay Garg
King's College Hospital, London, UK
Harminder S. Gill
King's College Hospital, London, UK
Katie Glover
Conquest Hospital, Hastings, UK
Stephanie Hicks
King's College Hospital, London, UK
Fritz-Patrick Jahns
King's College Hospital, London, UK
Sophie Maxwell
Walsall Manor Hospital, Walsall, UK
Blair Merrick
Hammersmith Hospital, London, UK
Madeline Moore
King's College Hospital, London, UK
Sarah Morrow
Hammersmith Hospital, London, UK
Rahul K. Mukherjee
King's College Hospital, London, UK
Anna Robinson
King's College Hospital, London, UK
Arvind Singhal
Imperial College Healthcare NHS Trust, London, UK
Nicholas Sunderland
King's College Hospital, London, UK
Anneline te Riele
University Medical Centre, Utrecht, The Netherlands
Maria Tsakok
Hammersmith Hospital, London, UK
Robert A. Watson
North West London Hospitals NHS Trust, London, UK
2D
two-dimensional
3D
three-dimensional
A2
aortic valve component of heart sound 2
AAA
abdominal aortic aneurysm
ABG
arterial blood gas
ABPM
ambulatory blood pressure monitoring
ACC
American College of Cardiology
ACE
angiotensin-converting enzyme
ACEi
angiotensin-converting enzyme inhibitor
ACR
albumin:creatinine ratio
ACS
acute coronary syndrome
ACTH
adrenocorticotropic hormone
ADP-P2Y
adenosine diphosphate-P2Y receptor
AF
atrial fibrillation
AHA
American Heart Association
AI
angiotensin I
AII
angiotensin II
AKI
acute kidney injury
ALD
alcoholic liver disease
ALP
alkaline phosphatase
ALS
advanced life support
AMA
American Medical Association
AMB
acute marginal branch
AMTS
Abbreviated Mental Test score
APS
antiphospholipid syndrome
aPTT
activated partial thromboplastin time
AR
aortic regurgitation
ARB
angiotensin-II receptor blocker
ARDS
acute respiratory distress syndrome
AS
aortic stenosis
ASD
atrial septal defect
AST
aspartate aminotransferase
ATP
adenosine triphosphate
AV
atrioventricular
AVN
atrioventricular node
AVNRT
AV-nodal re-entrant tachycardia
AVPU
alert/responsive to voice/responsive to pain/unresponsive
AVRT
atrioventricular re-entrant tachycardia
AVSD
atrioventricular septal defect
BAH
bilateral adrenocortical hyperplasia
BAV
balloon aortic valvuloplasty
BCS
British Cardiovascular Society
BD
twice a day
BE
base excess
beta-hCG
beta human chorionic gonadotrophin
BM
Boheringer-Mannheim – capillary glucose test
BMI
body mass index
BNP
brain natriuretic peptide
BP
blood pressure
BPH
benign prostatic hyperplasia
bpm
beats per minute
CABG
coronary artery bypass graft
CAC
coronary artery calcium
CAD
coronary artery disease
Cath Lab
(coronary) catheterization laboratory
CCB
calcium-channel blocker
CCF
congestive cardiac failure
CCP
cyclic citrullinated peptide
CCU
cardiac care unit
CK-MB
creatine kinase – MB isoform
CKD
chronic kidney disease
CMV
cytomegalovirus
CN
coagulase negative
CNS
central nervous system
CO
cardiac output
CoA
coarctation of the aorta
COPD
chronic obstructive pulmonary disease
COX
cyclo-oxygenase
CPAP
continuous positive airway pressure
CPR
cardiopulmonary resuscitation
CRP
C-reactive protein
CRT
cardiac resynchronization therapy
CRT-D
cardiac resynchronization therapy + cardiac defibrillator
CT
computed tomography
CTPA
computed tomography pulmonary angiogram
CTR
cardiothoracic ratio
CV(S)
cardiovascular (system)
CVA
cerebrovascular accident
CVD
cerebrovascular disease
CVP
central venous pressure
CXA
X-ray coronary angiography
CXR
chest X-ray
DAPT
dual anti-platelet therapy
DC
direct current
DCM
dilated cardiomyopathy
DH
drug history
DHP
dihydropyridine
DKA
diabetic ketoacidosis
DM
diabetes mellitus
DVLA
Driver and Vehicle Licensing Agency
DVT
deep vein thrombosis
EBV
Epstein–Barr virus
ECG
electrocardiogram
echo
echocardiogram
ED
emergency department
EDV
end-diastolic volume
EEG
electroencephalogram
EF
ejection fraction
EGDT
early goal-directed therapy
eGFR
estimated glomerular filtration rate
ELR
external loop recorder
EPS
electrophysiological study
ESC
European Society of Cardiology
ESM
ejection systolic murmur
ESR
erythrocyte sedimentation rate
ESV
end-systolic volume
EVAR
endovascular aneurysm repair
FAST
focused assessment with sonography for trauma
FBC
full blood count
FFP
fresh frozen plasma
FFR
fractional flow reserve
FH
family history
FY2
foundation year 2 doctor
G6PD
glucose-6-phosphate dehydrogenase
GCS
Glasgow coma scale
GFR
glomerular filtration rate
GI
gastrointestinal
GMP
guanosine monophosphate
GORD
gastro-oesophageal reflux disease
GP
general practitioner
GRA
glucorticoid-remediable aldosteronism
GRACE
Global Registry of Acute Coronary Events
GTN
glyceryl trinitrate
GZA
glycyrrhizic acid
HACEK
organisms associated with culture-negative infective endocarditis
Hb
haemoglobin
HbA1c
glycated haemoglobin
HBPM
home blood pressure monitoring
HCG
human chorionic gonadotrophin
HCM
hypertrophic cardiomyopathy
HDL
high density lipoprotein
HDU
high dependency unit
HF
heart failure
HF-PEF
heart failure with preserved ejection fraction
HF-REF
heart failure with reduced ejection fraction
HIT
heparin-induced thrombocytopenia
HIV
human immunodeficiency virus
HOCM
hypertrophic obstructive cardiomyopathy
HPC
history of the presenting complaint
HR
heart rate
HTN
hypertension
IABP
intra-aortic balloon pump
IC
intercostal
ICD
implantable cardioverting defibrillator
ICH
intracerebral haemorrhage
IE
infective endocarditis
IGG
immunoglobulin G
IHD
ischaemic heart disease
ILR
internal loop recorder
IM
intramuscular
INR
international normalized ratio
ISMN
isosorbide mononitrate
ITU
intensive therapy unit
IV
intravenous
IVCD
intraventricular conduction delay
IVDU
intravenous drug user
IVUS
intravascular ultrasound
JVP
jugular venous pulse/pressure
LA
left atrium
Lac
lactate
LAD
left anterior descending coronary artery
LBBB
left bundle branch block
LCx
left circumflex artery
LDH
lactate dehydrogenase
LDL cholesterol
low density lipoprotein cholesterol
LFT
liver function test
LGV
large goods vehicle
LL
left leg
LMA
laryngeal mask airway
LMCA
left main coronary artery
LMWH
low molecular weight heparin
LQTS
long QT syndrome
LV
left ventricular/left ventricle
LVEDP
left ventricular end-diastolic pressure
LVEDV
left ventricular end-diastolic volume
LVEF
left ventricular ejection fraction
LVESD
left ventricular end-systolic diameter
LVH
left ventricular hypertrophy
LVOT
left ventricular outflow tract
LVOTO
left ventricular outflow tract obstruction
MAHA
microangiopathic haemolytic anaemia
MAOI
monoamine oxidase inhibitor
MAP
mean arterial pressure
MAU
medical assessment unit
MCA
middle cerebral artery
MCV
mean corpuscular volume
MDCT
multi-detector row computed tomography
MDM
multidisciplinary meeting
MDT
multidisciplinary team
MEN
multiple endocrine neoplasia
MI
myocardial infarction
MIBG
meta-iodobenzylguanidine
MR
mitral regurgitation
MRA
mineralocorticoid receptor antagonist
MRI
magnetic resonance imaging
MS
mitral stenosis
MVP
mitral valve prolapse
NAC
N-acetylcysteine
NBM
nil by mouth
NICE
National Institute for Health and Care Excellence
NOAC
novel oral anticoagulant
NPA
nasopharyngeal mask airway
NSAID
non-steroidal anti-inflammatory drug
NSTE ACS
non-ST-elevation acute coronary syndrome
NSTEMI
non-ST-elevation myocardial infarction
NYHA
New York Heart Association
OCT
optical coherence tomography
OD
once a day
OMB
obtuse marginal artery
OMT
optimal medical therapy
OR
odds ratio
OSCE
objective structured clinical examination
P2
pulmonary valve constituent of the second heart sound
PAD
peripheral arterial disease
P
a
O
2
partial pressure of arterial oxygen
PCA
patient-controlled analgesia
PCC
prothrombin complex concentrate
PCI
percutaneous coronary intervention
PCR
protein:creatinine ratio
PCV
passenger-carrying vehicle
PDA
patent ductus arteriosus
PDE-5
phosphodiesterase-5
PE
pulmonary embolism
PEF
peak expiratory flow
PET
positron emission tomography
PFO
patent foramen ovale
PG
prostaglandin
PICC
peripherally inserted central catheter
PLV
posterior left ventricular branch
PMC
percutaneous mitral commisurotomy
PMH
past medical history
PND
paroxysmal nocturnal dyspnoea
PO
per os
- taken orally
PP
pulse pressure
PPI
proton-pump inhibitor
PR
per rectum
PRN
pro re nata
– as needed
PT
prothrombin time
PUO
pyrexia of unknown origin
PVI
pulmonary vein isolation
QDS
four times a day
QTc
corrected QT interval
RA
right atrium
RAA
renin–angiotensin–aldosterone
RBBB
right bundle branch block
RCA
right coronary artery
RCM
restrictive cardiomyopathy
RCT
randomized controlled trial
RF
risk factor
ROSC
return of spontaneous circulation
RR
respiratory rate
RRR
relative risk reduction
RV
right ventricular
RVOT
right ventricular outflow tract
RVST
right ventricular systolic pressure
S1
heart sound 1
S2
heart sound 2
S3
heart sound 3
S4
heart sound 4
SAN
sinoatrial node
S
a
O
2
saturation of arterial oxygen
SAVR
surgical aortic valve replacement
SBAR
situation/background/assessment/recommendation
SC
subcutaneously
SG
specific gravity
SHO
senior house officer
SIRS
systemic inflammatory response syndrome
SLE
systemic lupus erythematosus
SOB
shortness of breath
SOBOE
shortness of breath on exertion
SPECT
single-photon emission computed tomography
SpO
2
oxygen saturation
SpR
specialist registrar
SSRI
selective serotonin reuptake inhibitor
STE ACS
ST-elevation acute coronary syndrome
STEMI
ST-elevation myocardial infarction
SV
stroke volume
SVC
superior vena cava
SVR
systemic vascular resistance
SVT
supraventricular tachycardia
T-LOC
transient loss of consciousness
TA
transapical
TAVI
transaortic valve implantation
TB
tuberculosis
TDS
three times a day
TF
transfemoral
TFT
thyroid function test
TGA
transposition of the great arteries
TIA
transient ischaemic attack
TIMI
Thrombolysis In Myocardial Infarction (study)
TOE
transoesophageal echocardiogram
TR
tricuspid regurgitation
TSH
thyroid-stimulating hormone
TTE
trans-thoracic echocardiogram
TXA2
thomboxane A2
U&E
urea and electrolytes
UA
unstable angina
UFH
unfractionated heparin
USS
ultrasound scan
UTI
urinary tract infection
VBG
venous blood gas
VF
ventricular fibrillation
VKA
vitamin K antagonist
VSD
ventricular septal defect
VT
ventricular tachycardia
VTE
venous thromboembolism
WCC
white cell count
WHO
World Health Organization
WPW
Wolff–Parkinson–White syndrome
This book is accompanied by a companion website:
www.wiley.com/go/camm/cardiology
The website includes:
MCQs
EMQs
SAQs
Clinical cases
Audio
Audio scripts
Christian F. Camm
John Radcliffe Hospital, Oxford, UK
Arrhythmias
Valvular pathology
Endocarditis
Heart failure
Ischaemic heart disease
Inherited cardiac conditions
Poor perfusion/shock
Anaemia
Table 1.1 Elements to be undertaken prior to examining the patient
Item
Detail
1. Appropriate hand hygiene
Wash hands with soap and water or alcohol hand rub
2. Introduce yourself
Full name and job title
3. Confirm patient identity
Check full name and date of birth, verify against wrist band
4. Gain permission for the examination
Explain your role and what the examination will involve
5. Enquire about pain
Particularly chest and shoulder pain
6. Position the patient
45° on examination couch or bed
7. Expose the patient appropriately
Entire chest (women can leave bras on) Remember to cover patient when not examining the chest itself
Table 1.2 Examination features from the end of the bed
Item
Detail
1. Does the patient look well?
Sitting up and talking, or reduced consciousness?
Difficulty breathing?
Severe cyanosis?
Pallor?
Sweating?
2. Are there any obvious scars?
Midline sternotomy
Lateral thoracotomy
Saphenous vein harvest scar
Pacemaker/ICD device or scar
3. Lines in and out of patient
IV infusions
Catheters
Oxygen
4. Patient monitoring
Continuous ECG
Pulse oximetry
Haemodynamic monitoring (e.g. blood pressure)
5. Any medications around the patient
Glyceryl trinitrate (GTN) spray or inhalers
Drug infusions
Warfarin (or anticoagulation cards/booklets)
Table 1.3 Examination findings in the nails
Item
Conditions
1. Clubbing
/
2. Splinter haemorrhages
3. Capillary refill time >2 seconds
4. Peripheral cyanosis
/
5. Nicotine stains
Fluctuation and softening of the nail bed
Loss of normal nail bed angle (Lovibond's angle)
Increased convexity of the nail fold
Thickening of the whole distal finger
Striations and increased shine on nails and surrounding skin
Table 1.4 Examination findings in the hand
Item
Conditions
1. Tendon xanthomata
/
2. Osler nodes
3. Janeway lesions
4. Palmar crease pallor
5. Temperature
6. Bruising (anticoagulation or antiplatelet agents)
Table 1.5 Examination findings in the wrist
Item
Conditions
1. Pulse rate
/
2. Pulse rhythm
3. Radio-radial delay
4. Radio-femoral delay
5. Collapsing pulse
6. Blood pressure
/ / /
Table 1.6 Examination findings in the eyes
Item
Conditions
1. Corneal arcus
/age
2. Conjunctival pallor
3. Petechial haemorrhages
4. Xanthelasma over eyelids
5. Roth spots
6. Lens dislocation
Table 1.7 Examination findings in the mouth
Item
Conditions
1. Hydration status
general
2. Dentition
3. Central cyanosis
/
4. High arched palate (Marfan's)
Table 1.8 Examination findings in the neck
Item
Conditions
1. Carotid pulse – character
/
2. JVP
Located between heads of sternocleidomastoid
JVP has double pulse (rather than single found in carotid)
JVP can be occluded
JVP may be made more visible by lowering angle of the bed
Hepato-jugular reflux
Height measured from the sternal angle (angle of Louis)
Slow rising:
aortic stenosis
Small volume:
tachycardia, volume depletion, cardiogenic shock, aortic stenosis
Bounding:
CO
2
retention, Paget's disease, aortic regurgitation
Collapsing:
aortic regurgitation
Pulsus bisferiens:
combined aortic stenosis and regurgitation
Table 1.9 Examination findings in the legs. This is often undertaken after examining the praecordium
Item
Conditions
Pitting oedema
Saphenous vein harvest scars
Table 1.10 Inspection features of the praecordium
Item
Conditions
1. Scars
/ /
2. Pacemaker/ICD
/
3. Visible apex beat
/
Table 1.11 Palpation features of the praecordium
Item
Conditions
1. Apex beat
2. Thrills
(aortic and pulmonary valve pathology)
3. Right ventricular heave
/
Most lateral and inferior precordial cardiac pulsation
Normal position – fifth intercostal space, inside mid-clavicular line
Lateral and inferior displacement represents LV dilation
Diffuse apex beat represents LV dilation
Tapping of the apex beat is seen in mitral stenosis
Double impulse is a sign of hypertrophic obstructive cardiomyopathy
Table 1.12 Auscultation of the praecordium
Location
Valve auscultated
1. Apex
Mitral valve
2. Fourth intercostal (IC) space, left sternal edge
Tricuspid valve + aortic (regurgitation)
3. Second IC space, left sternal edge
Pulmonary valve
4. Second IC space, right sternal edge
Aortic (stenosis)
5. Axilla
Mitral (reguritation)
6. Carotids
Aortic (stenosis) + carotid bruits
To be successful at auscultation, it is important to actively listen (ask yourself what you can hear)
The auscultatory elements that make up each cardiac cycle must be identified
When identified, each component should then be characterized:
First heart sound:
mitral and tricuspid valve closure
Second heart sound:
aortic and pulmonary valve closure
Additional sounds:
S3, S4
Murmurs
Non-valvular sounds:
e.g. pericardial rub
Mechanical heart valve sounds
Rolled to left side:
for mitral valve murmurs
Hold breath in expiration:
left-sided murmurs
Hold breath in inspiration:
right-sided murmurs
Sit patient forward:
aortic regurgitation
Caused by blood hitting the closed mitral and tricuspid valves
Represents the start of ventricular systole
Usually a single sound
Heard best at the cardiac apex
Split sound:
bundle branch block
Soft S1:
first-degree AV block, aortic regurgitation
Loud S1:
mitral stenosis
Variable intensity:
ventricular arrhythmias, variable AV block
Caused by blood hitting the closed aortic and pulmonary valves
Represents the end of ventricular systole
Heard well over the entire praecordium
Usually a split sound on inspiration
Pulmonary component follows aortic
Widely split:
right bundle branch block
Fixed splitting:
atrial septal defects
Soft aortic component:
aortic stenosis
Table 1.13 Examination findings on the back
Item
Conditions
Lung bases
Sacral oedema
Figure 1.1 The examination circuit.
(See Audio Podcast 1.1 at www.wiley.com/go/camm/cardiology)
An approach that works well when not sure of your findings
Useful for objective structured clinical examinations (OSCEs) to ensure that information is not missed
Discuss the positive findings (and key negatives) in the order that you examined
Give a potential diagnosis after presenting findings
I examined this 52-year-old patient. He presented with shortness of breath and leg swelling. On inspection he was clearly dyspnoeic but otherwise appeared well. He was alert. There was a well healed midline sternotomy scar. His pulse was regular at 80 bpm. His blood pressure was 110/80 mmHg. The patient was well hydrated. The JVP was raised by 8 cm. There were no additional peripheral signs elucidated. On the praecordium he had no additional scars. His apex beat was not inappropriately located. On auscultation S1 and S2 were both heard. Additionally a third heart sound was heard across the praecordium. There were no additional sounds. There were inspiratory crackles at the lung bases and some sacral oedema. A clear scar along the course of the long saphenous vein was seen on the left leg, this was combined with bilateral pitting oedema reaching the mid-calf.
In conclusion, this patient presents with shortness of breath and signs suggestive of heart failure.
An approach to be used when you are confident or pressed for time
Give your suspected diagnosis first
Discuss the examination findings that support the diagnosis and help to exclude others
Discuss findings in the order of most supportive to least supportive of your diagnosis
I examined this 52-year-old patient. He presented with shortness of breath and leg swelling. Examination revealed a patient with a clinical picture of congestive heart failure. This was supported by findings of inspiratory crackles at the lung bases, pitting oedema in the sacral region and bilaterally in the legs up to the mid-calf level. In addition, the JVP was raised to 8 cm above the angle of Louis. On auscultation S1 and S2 were clearly heard with the addition of a third heart sound. The patient has a history of coronary artery bypass surgery as supported by the midline sternotomy scar and long saphenous vein graft scar on the left leg. Given these findings, this suggests a history of heart failure potentially secondary to ischaemic heart disease.
Table 1.14 Eponymous signs in cardiology
Eponym
Details
Austin Flint murmur
Low-pitched rumbling murmur in mid-diastole due to aortic regurgitation causing mitral stenosis
Beck's triad
Three signs associated with cardiac tamponade:
Low arterial blood pressure
Distended neck veins
Muffled heart sounds
Corrigan's pulse
A large-volume pulse which collapses away due to aortic regurgitation – observed at the carotid
De Musset's sign
Rhythmic nodding of the head due to increased pulse pressure in aortic regurgitation
Duroziez's sign
Compression of the femoral artery with the bell of the stethoscope leads to an audible diastolic murmur – aortic regurgitation
Ewart's sign
Collection of signs at the left lung base due to pericardial effusion:
‘Woody’ dullness to percussion
Increased vocal resonance
Bronchial breath sounds
Friedreich's sign
Significant drop in JVP during the diastolic phase due to constrictive pericarditis
Graham Steell murmur
Pulmonary regurgitant murmur heard in the left 2
nd
intercostal space
Janeway lesions
Non-tender, small erythematous nodular lesions on the palms/soles indicative of endocarditis
Kussmaul's sign
Paradoxical rise in JVP on inspiration, indicative of reduced right ventricular filling (e.g. right heart failure or constrictive pericarditis)
Mayne's sign
A drop >15 mmHg in diastolic blood pressure when the arm is raised – aortic regurgitation
Müller's sign
Bobbing of the uvula due to wide pulse pressure of aortic regurgitation
Oliver's sign
Downward tug of the trachea during systole – aneurysm of the aortic arch
Osler nodes
Painful, raised lesions on the hands/feet caused by immune complex deposition and suggestive of infective endocarditis
Osler's sign
Falsely elevated blood pressure due to calcification of the vessels
Quinke's pulse
Alternating blushing and blanching of the fingernails – aortic regurgitation
Roth spots
Retinal haemorrhages with a pale fibrin centre caused by immune complex deposition and suggestive of infective endocarditis
Still's murmur
Innocent flow murmur
Watson's waterhammer pulse
As with Corrigan's pulse, but observed over the radial artery
For additional resources and to test your knowledge, visit the companion website at:
1. Arrhythmias 2. Valvular pathology 3. Endocarditis 4. Heart failure 5. Ischaemic heart disease 6. Inherited cardiac conditions 7. Poor perfusion/shock 8. Anaemia
Maria Tsakok
Hammersmith Hospital, London, UK
Any pain or discomfort that is felt to originate in and around the thorax.
Figure 2.1 Algorithm for the diagnosis of chest pain.
Acute coronary syndrome
Aortic dissection
Pulmonary embolism
Tension pneumothorax
Boerhaave's syndrome (oesophageal rupture)
Cardiac causes
Stable angina
Pericarditis
Pulmonary causes
Pneumonia
Pneumothorax
Gastrointestinal causes
Gastro-oesophageal reflux disease
Oesophageal spasm
Musculoskeletal causes
Rib contusions/fractures
Intercostal muscle strains
Costochondritis (including Tietze and Bornholm syndromes)
Psychiatric causes
Herpes zoster
(See Audio Podcast 2.1 at www.wiley.com/go/camm/cardiology)
Diagnosis: Acute coronary syndrome
Questions
a. Is the pain crushing or heavy in nature?
These are the typical descriptions, but the pain may also be described as tight, gripping or pressing.
b. Does the pain radiate to the left arm or jaw?
These distinctive sites of radiation are highly suggestive of myocardial pain.
c. Are there associated autonomic symptoms?
Commonly nausea/vomiting and sweating.
d. Are there any cardiac risk factors?
See Box 2.1.
Non-modifiable:
Increasing age
Male gender
Family history
Previous cardiovascular events
Diabetes
Modifiable:
Smoking
Hypertension
Obesity
Low physical activity
Diagnosis: Aortic dissection
Questions
a.
